Research and Resources

Research centres and regulators

International research centres

Australian regulatory agencies

Recent publications

A range of additional research will be added shortly.

Current or recent research in Australia and New Zealand

Current or recent medicinal psychedelics research led by researchers/institutions in Australia or New Zealand.

  • Title: Global Cross-sectional study of the health and wellbeing harms and benefits associated with consumption of ayahuasca. Cross-sectional observational study of  >7000 ayahuasca drinkers in over 50 countries (current).
    Investigators: Dr D Perkins, Dr V D Schubert, A/Prof J Sarris, Dr J Carlos Bouso, Dr M Horák, Dr M Scheidegger, Ms H Simonova, Professor L Tófoli, Dr. E Opaleye.
    Lead Institution (contact): University of Melbourne (Dr Daniel Perkins d.perkins@unimelb.edu.au)
  • Title: Mental health, addiction and wellbeing effects associated with the use of ayahuasca tea in religious contexts. Longitudinal observational study at two sites (current).
    Investigators: Dr D J Perkins, A/Prof R D Chenhall, A/Prof J Sarris.
    Lead Institution (contact): University of Melbourne (Dr Daniel Perkins d.perkins@unimelb.edu.au)
  • Title: Multi-site study investigating the mental health, addiction and wellbeing effects of ayahuasca consumption in facilitated contexts. Multi-site longitudinal observational study, with comparison group (current).
    Investigators: Dr D J Perkins, A/Prof R D Chenhall, A/Prof J Sarris.
    Lead Institution (contact): University of Melbourne (Dr Daniel Perkins d.perkins@unimelb.edu.au)
  • Title: Psilocybin-assisted psychotherapy for the treatment of depression and anxiety associated with life-threatening illness. Interventional RCT (current)
    Investigators: M.Ross, J.Dwyer, M.Williams
    Lead Institution (contact): St Vincent’sHospital (Dr Margaret Ross margaret.ross@svha.org.au)
  • Title: Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial (KGAD). Interventional RTC (completed).
    Investigators: Sarris J., Savage KM, Stough CK, Byrne GJ, Scholey A, Bousman C, Murphy J, Macdonald P, Suo C, Hughes M, Thomas S, Teschke R, Xing C.
    Lead Institution (contact): University of Melbourne (A/Prof Jerome Sarris jsarris@unimelb.edu.au)
  • Title: A systematic study of microdosing psychedelics. Cross-sectional observational study (completed).
    Investigators: Vince Polito , Richard J. Stevenson
    Lead Institution (contact): Macquarie University (Dr Vince Polito vince.polito@mq.edu.au)
  • Title: Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. Longitudinal observational (completed).
    Investigators: G. Noller, C. Frampton, B. Yazar-Klosinski.
    Lead Institution (contact): University of Otago (Dr Geoff Noller Geoff.noller@otago.ac.nz)
  • Title: Ascending Single‐Dose, Double‐Blind, Placebo‐Controlled Safety Study of Noribogaine in Opioid‐Dependent Patients. Interventional RCT (completed)
    Investigators: P. Glue, G. Cape, D. Tunnicliff, M. Lockhart, F. Lam, N. Hung, C. Hung, S. Harland, J. Devane, R. Crockett, J. Howes, B. Darpo, M. Zhou, H. Weis, L. Friedhoff.
    Lead Institution (contact): University of Otago (Prof Paul Glue paul.glue@otago.ac.nz